Images List Premium Download Classic

Cardiovascular

Cardiovascular-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
NEW Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions
Ubiome, Inc.
May 17, 2018 - N°20180137931

A method for at least one of characterizing, diagnosing, and treating a cardiovascular disease condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the ...
NEW Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions
Ubiome, Inc.
May 17, 2018 - N°20180137930

A method for at least one of characterizing, diagnosing, and treating a cardiovascular disease condition in at least a subject, the method comprising: receiving an aggregate set of biological samples from a population of subjects; generating at least one of a microbiome composition dataset and a microbiome functional diversity dataset for the population of subjects; generating a characterization of the ...
NEW Citrullinated proteins: a post-translated modification of myocardial proteins as marker of physiological and pathological disease
Cedars-sinai Medical Center
May 17, 2018 - N°20180136232

Disclosed herein are methods for diagnosing cardiovascular disease. The methods comprise detection of citrullinated proteins and/or citrullinated peptides. Also disclosed herein are methods, compositions, and kits for diagnosing and/or treating cardiovascular disease.
NEW Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Rnai inhibitors of glucose-6-phosphate dehydrogenase for treating cardiovascular and pulmonary conditions
May 17, 2018 - N°20180135049

The present disclosure provides for methods of treating or preventing a cardiovascular disorder and/or a related pulmonary disorder in a subject. In certain embodiments, a therapeutically effective amount of a polynucleotide inhibitor of glucose-6-phosphate dehydrogenase (g6pd) or a nucleic acid encoding g6pd is administered.
NEW Benzoxazinone derivatives and analogues thereof as modulators of tnf activity
Ucb Biopharma Sprl
May 17, 2018 - N°20180134728

A series of substituted 3,4-di-hydro-2h-. 1,4-benzoxazin-3-one derivatives, and analogues thereof, being potent modulators of human tnfα activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.
NEW Use of ginseng extract, ginsenoside and ginsenoside derivative in the preparation of medicine or health ...
May 17, 2018 - N°20180133273

The invention discloses new application of a ginseng extract, ginsenoside and a ginsenoside derivative in the preparation of a medicine for treating hcmv infection related diseases. The related diseases comprise hcmv infection caused in the process of treating cardiovascular and cerebrovascular diseases, organ transplantation, perinatal periods, tumors, burn, aids and other diseases of patients. Tests prove that the ginseng extract, ...
NEW Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
NEW Treatment of nash with gemcabene
Gemphire Therapeutics Inc.
May 17, 2018 - N°20180133177

Methods and formulations to reduce elevated levels of lipids and apolipoprotein b in subjects having type iib hyperlipidemia. Methods for preventing, delaying or regressing complications of lipid disorders, including; type iib hyperlipidemia, nafld, and nash. Methods for preventing or delaying primary and secondary cardiovascular events. Kits useful for such methods. Methods for reducing hepatic fibrosis. Methods for reducing plasma fibrinogen ...
A method for predicting the risk of incidence of chronic kidney diseases
Sphingotec Gmbh
May 10, 2018 - N°20180128838

The present invention relates to means and methods suitable for risk prediction of chronic kidney disease (ckd) using pro-enkephalin or fragments thereof as biomarker. The risk prediction methods of the invention are intended for healthy subjects and for subjects suffering from diseases such as hypertension, cardiovascular diseases and events, diabetes, metabolic syndrome, obesity, or autoimmune diseases. Subject matter of the ...
Method for the prognosis and/or diagnosis of an illness based on a sample of ...
Lipozyt Marker Ug
May 10, 2018 - N°20180127826

The invention relates to a method for the prognosis of adiposity and the prognosis and/or diagnosis of a disease selected from the group consisting of diabetes, cardiovascular diseases and metabolic syndrome.
Antigen-binding proteins that antagonize leptin receptor
Regeneron Pharmaceuticals, Inc.
May 10, 2018 - N°20180127508

The present invention provides antibodies and antigen-binding fragments of antibodies that bind to leptin receptor (lepr), and methods of using the same. According to certain embodiments, the invention includes antibodies and antigen-binding fragments of antibodies that bind lepr and antagonize lepr signaling. In certain embodiments, the invention includes antibodies and antigen-binding fragments of antibodies that bind lepr in the presence ...
Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
May 10, 2018 - N°20180127425

Wherein r1a, r1b, r2, r4, r5, r6, r7, r8, w, x, y, z, cy, and the subscript a are as defined herein. The present invention relates to compounds inhibiting autotaxin (npp2 or enpp2), methods for their production, pharmaceutical compositions comprising the same, and methods of treatment using the same, for the prophylaxis and/or treatment of diseases involving ...
Benzothiazole or benzoxazole compounds as sumo activators
Icahn School Of Medicine At Mount Sinai
May 10, 2018 - N°20180127407

Provided are sumo activators, which can enhance sumoylation of serca2a, which are useful in the treatment of heart failure, cardiovascular diseases, cancer, neurodegenerative disorders, viral infection, bacterial infection, liver disease, inflammation, and other diseases.
Compounds
May 10, 2018 - N°20180127405

And salts thereof are kmo inhibitors and may be useful in the treatment of various disorders, for example acute pancreatitis, chronic kidney disease, acute kidney disease, acute kidney injury, other conditions associated with systemic inflammatory response syndrome (sirs), huntington's disease, alzheimer's disease, spinocerebellar ataxias, parkinson's disease, aids-dementia complex, hiv infection, amylotrophic lateral sclerosis (als), depression, schizophrenia, sepsis, cardiovascular shock, severe ...
Cardiovascular Patent Pack
Download 516+ patent application PDFs
Cardiovascular Patent Applications
Download 516+ Cardiovascular-related PDFs
For professional research & prior art discovery
inventor
  • 516+ full patent PDF documents of Cardiovascular-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Nitrite salts of 1,1-dimethylbiguanide, pharmaceutical compositions, and methods of use
Novomedix, Llc
May 10, 2018 - N°20180127359

Provided herein are nitrite salts of 1,1-dimethylbiguanide; and isotopic variants thereof; and pharmaceutically acceptable hydrates and solvates thereof. Also provided herein are their pharmaceutical compositions and methods of use for treating, preventing, or ameliorating one or more symptoms of diseases associated with and/or caused by an abnormal blood glucose level. Further provided herein are methods of their use for ...
Extraction of resveratrol from waste biomass derived from grapes processing
May 10, 2018 - N°20180127342

The invention describes the extraction method to obtain the highest amount of resveratrol from wasted biomass produced by grapes processing. Resveratrol, which is found rich in the grapes, especially in grape skin and seed, is one of the most potent antioxidant, and can help to fight cell-damaging free radicals and promote cardiovascular health. Based on the most performing extraction methods ...
System and method of fitness training in virtual environment
Hashplay Inc.
May 10, 2018 - N°20180126247

A system for fitness training in a virtual environment. The system includes a cardiovascular training equipment, a head mounted device for presenting a video content associated with the virtual environment, and at least one computing device communicably coupled to the cardiovascular training equipment and the head mounted device. The at least one computing device is operable to provide the video ...
Autoimmune mechanical immunomodulation
Amina Sciences Llc
May 10, 2018 - N°20180126060

The present disclosure describes a novel therapeutic apheresis system and, more specifically, methods and an apparatus for performing therapeutic apheresis. The present disclosure provides highly efficient methods for therapeutic apheresis that modulate the immune system, thereby resulting in treatment of one or more underlying immunological disease processes. In some embodiments, the disclosed methods return at least a portion of blood ...
Virus-like particle with efficient epitope display
University Of Copenhagen
May 10, 2018 - N°20180125954

The invention relates to a virus-like particle (vlp) based vaccine. The virus-like particle constitutes a non-naturally occurring, ordered and repetitive antigen array display scaffold which can obtain a strong and long-lasting immune response in a subject. The vlp-based vaccine may be used for the prophylaxis and/or treatment of a disease including, but is not limited to, cancer, cardiovascular, infectious, ...
Compositions and methods for treatment of cardiovascular disorders
Cormatrix Cardiovascular, Inc.
May 10, 2018 - N°20180125896

Ecm based compositions including amniotic membrane and methods for employing same to treat cardiovascular disorders.
Methods and formulations for modulating lyn kinase activity and treating related disorders
Melior Pharmaceuticals I, Inc.
May 10, 2018 - N°20180125845

The present invention relates to compounds and pharmaceutically acceptable salts thereof and formulations comprising the compounds or a pharmaceutically acceptable salts thereof that are useful in modulating lyn kinase activity. In particular, the compounds or a pharmaceutically acceptable salts thereof are useful for treating or preventing a disease or disorder including cardiovascular disease, dyslipidemia, dyslipoproteinemia, a disorder of glucose metabolism, ...
Pharmaceutical composition, methods for treating and uses thereof
Boehringer Ingelheim International Gmbh
May 10, 2018 - N°20180125813

The present invention relates to methods for treating or preventing chronic kidney disease and cardiovascular disease in patients with chronic kidney disease comprising administering empagliflozin to the patient.
Loading